| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.07 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.099 | 0.07 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.061 | 0.07 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.07 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.07 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.07 |